SCHEMBL4856705

SCHEMBL4856705

CC(C)(C)OC(=O)NCCNC(=O)CC(CCNC(=O)OCc1ccccc1)N(C(=O)O)C(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.48
MAPT P10636 2/20 0.48
SLC1A3 P43003 1/20 0.45
SLC1A1 P43005 1/20 0.45
KLK7 P49862 2/20 0.44
KLK5 Q9Y337 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 2/20 0.43
IDO1 P14902 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.42
HTT P42858 1/20 0.41
DPP8 Q6V1X1 1/20 0.41
DPP7 Q9UHL4 1/20 0.41
FOLH1 Q04609 1/20 0.40
MMP2 P08253 2/20 0.40
MMP3 P08254 2/20 0.40
MMP9 P14780 2/20 0.40
MMP14 P50281 2/20 0.40
MMP1 P03956 1/20 0.40
MMP7 P09237 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4850916 0.88 SYK (0.52) SYKMAPTSLC1A3SLC1A1KLK7
SCHEMBL1024723 0.85 CPB1 (0.47) MAPTSLC1A3SLC1A1SMN1; SMN2LMNA
SCHEMBL1024135 0.84 CTSS (0.41) SYKIDO1MMP3MMP9MMP1
Acetic Acid SCHEMBL4856558 0.84 CPB1 (0.46) MAPTSLC1A3SLC1A1SMN1; SMN2LMNA
SCHEMBL15202883 0.80 SYK (0.64) SYKMAPTSLC1A3SLC1A1KLK7
SCHEMBL30544325 0.79 SYK (0.57) SYKMAPTKLK7KLK5SMN1; SMN2
SCHEMBL5574078 0.79 SYK (0.57) SYKMAPTKLK7KLK5SMN1; SMN2
SCHEMBL13480455 0.78 SYK (0.66) SYKMAPTSLC1A3SLC1A1KLK7
SCHEMBL22657971 0.78 SYK (0.56) SYKMAPTKLK7KLK5SMN1; SMN2
SCHEMBL1024168 0.77 MAPT (0.51) SYKMAPTKLK7KLK5L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7446102-B2 Antibacterial amide macrocycles IV AICURIS GMBH & CO. KG (DE) 2008-11-04 US disclosed
US-20080076745-A1 ANTIBACTERIAL AMIDE MACROCYCLES IV AICURIS GMBH & CO. KG (DE) 2008-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076745-A1 ANTIBACTERIAL AMIDE MACROCYCLES IV NOD2, AAAS, AADAC SYK 3060/4885MAPT 4356/4885SLC1A3 3963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.